LMB89 protocol

chemotherapy protocol consisting of above cpds for the treatment of B-cell lymphomas and L3 leukemia

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - LMB89 protocol: 4
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - LMB89 protocol: 4
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - LMB89 protocol: 4
Heterocyclic Compounds: 198
Enzymes and Coenzymes: 1
- Coenzymes: 558
  - Tetrahydrofolates: 8
    - Formyltetrahydrofolates
      - Leucovorin: 5743
        LMB89 protocol: 4
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        Tetrahydronaphthalenes: 1
        Podophyllotoxin: 562
        Etoposide: 10706
        LMB89 protocol: 4
        Naphthacenes
        Anthracyclines: 9423
        Daunorubicin: 2641
        Doxorubicin: 35390
        LMB89 protocol: 4
  - Halogenated Hydrocarbons: 42
    - Mustard Compounds: 3
      - Nitrogen Mustard Compounds: 2
        Phosphoramide Mustards: 5
        Cyclophosphamide: 25473
        LMB89 protocol: 4
- Organophosphorus Compounds: 300
  - Phosphoramides: 8
    - Phosphoramide Mustards: 5
      - Cyclophosphamide: 25473
        LMB89 protocol: 4
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Pyrimidine Nucleosides: 50
    - Cytidine: 535
      - Cytarabine: 6662
        LMB89 protocol: 4
  - Arabinonucleosides: 1
    - Cytarabine: 6662
      - LMB89 protocol: 4
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - Tetrahydronaphthalenes: 1
      - Podophyllotoxin: 562
        Etoposide: 10706
        LMB89 protocol: 4
  - Naphthacenes
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        LMB89 protocol: 4
- Fused-Ring Compounds
  - Steroids: 70059
    - Pregnanes: 9
      - Pregnenes: 1
        Pregnenediones
        Hydrocortisone: 24422
        LMB89 protocol: 4
      - Pregnadienes
        Pregnadienediols
        Prednisone: 12650
        LMB89 protocol: 4
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        LMB89 protocol: 4
  - Glucosides: 639
    - Etoposide: 10706
      - LMB89 protocol: 4
Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 80400
  - Adrenal Cortex Hormones: 62914
    - Hydroxycorticosteroids: 7
      - 17-Hydroxycorticosteroids: 179
        Hydrocortisone: 24422
        LMB89 protocol: 4
      - 11-Hydroxycorticosteroids: 56
        Hydrocortisone: 24422
        LMB89 protocol: 4

Experts

1.	Patte, C: 2 articles (05/2002 - 06/2001)
2.	Société Française d'Oncologie Pédiatrique: 2 articles (05/2002 - 06/2001)
3.	Estella, Jesús: 1 article (05/2007)
4.	Fernández-Delgado, Rafael: 1 article (05/2007)
5.	Forns, Marga: 1 article (05/2007)
6.	Gallego, Soledad: 1 article (05/2007)
7.	García-Miguel, Purificación: 1 article (05/2007)
8.	Indiano, José M: 1 article (05/2007)
9.	Javier, Germán: 1 article (05/2007)
10.	Navajas, Aurora: 1 article (05/2007)

Related Diseases

1.	B-Cell Lymphoma (Lymphoma, B Cell) 05/05/2007 - "The results confirm the good efficiency of the LMB89 protocol for treating B-cell lymphoma and L3 leukemia, despite having diminished the treatment intensity in the less risk groups. " 06/01/2001 - "The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia." 05/01/2002 - "Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol."
2.	Leukemia 05/01/2002 - "Retrospective review of the clinical records of 410 patients with stage III and IV B-cell NHL and L3 leukemia treated in France and prospectively registered in the LMB89 protocol. " 05/05/2007 - "The results confirm the good efficiency of the LMB89 protocol for treating B-cell lymphoma and L3 leukemia, despite having diminished the treatment intensity in the less risk groups. " 06/01/2001 - "The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia." 05/01/2002 - "Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol."
3.	Neoplasms (Cancer) 06/01/2001 - "The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia."
4.	Burkitt Lymphoma (Burkitt's Lymphoma) 02/01/2005 - "We report our results in a serie of 95 children with Burkitt lymphoma treated between September 1990 and December 2000 according to SFOP LMB89 protocol. " 02/01/2005 - "[Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca]."

Related Drugs and Biologics

1.	Urate Oxidase (Uricase)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)